Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications
Consolidation Therapy Based on Mutation Clearance in Acute Myeloid Leukemia.
Journal: NEJM evidence
Published: August 25, 2026
Personalized Neoantigen Vaccines Synergize with Immune Checkpoint Therapy and CD8-Targeted Cytokines to Control B-Cell Lymphoma.
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2026
Surveying the Genomic Landscape of Mantle Cell Lymphoma Indicates the Importance of Multimodal Genomic and Transcriptomic Exploration.
Journal: medRxiv : the preprint server for health sciences
Published: August 20, 2026
Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 14, 2026
Automating neoantigen selection for personalized cancer vaccine design.
Journal: medRxiv : the preprint server for health sciences
Published: July 10, 2026
pVACtools v6: A comprehensive suite for neoantigen prediction, visualization, and therapy design.
Journal: ArXiv
Published: July 03, 2026
Pumping up immunity: exercise flexes memory NK cell attack.
Journal: Blood advances
Published: April 14, 2026
A new immunotherapy ROR: Proximal ROR1 domain targeting breast cancer via monoclonal antibodies and CAR NK cells.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 05, 2026
ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trials.
Journal: ArXiv
Published: December 19, 2025
Exome sequencing of Hodgkin and non-Hodgkin composite lymphomas identifies shared somatic mutations indicative of common founding precursors.
Journal: Cancer genetics
Published: September 09, 2025
NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 06, 2025
ACLY promotes NK cell effector function by regulating glycolysis and histone acetylation.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: April 25, 2025
Last Updated: 09/26/2026